| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cell adhesion molecule binding | FLNA FLNB NRXN3 DCHS1 CPE NECTIN3 ITGA2B PPP1R13L ITGAD CD200R1L ITGAM ADAM8 ADAM22 PTPRT PCMT1 | 1.45e-07 | 599 | 95 | 15 | GO:0050839 |
| GeneOntologyMolecularFunction | peptidyl-proline 4-dioxygenase activity | 5.74e-06 | 8 | 95 | 3 | GO:0031545 | |
| GeneOntologyMolecularFunction | peptidyl-proline dioxygenase activity | 2.22e-05 | 12 | 95 | 3 | GO:0031543 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 2.25e-05 | 35 | 95 | 4 | GO:0015020 | |
| GeneOntologyMolecularFunction | L-ascorbic acid binding | 1.12e-04 | 20 | 95 | 3 | GO:0031418 | |
| GeneOntologyMolecularFunction | procollagen-proline 4-dioxygenase activity | 2.22e-04 | 5 | 95 | 2 | GO:0004656 | |
| GeneOntologyMolecularFunction | calcium- and calmodulin-responsive adenylate cyclase activity | 2.22e-04 | 5 | 95 | 2 | GO:0008294 | |
| GeneOntologyMolecularFunction | procollagen-proline dioxygenase activity | 6.16e-04 | 8 | 95 | 2 | GO:0019798 | |
| GeneOntologyMolecularFunction | transcription factor binding | EOMES FLNA WIPI1 IRX5 NAAA PPP1R13L JMJD1C PTPRT RBFOX2 FOXC1 THAP7 | 8.93e-04 | 753 | 95 | 11 | GO:0008134 |
| GeneOntologyMolecularFunction | peptidase activity | 1.10e-03 | 654 | 95 | 10 | GO:0008233 | |
| GeneOntologyMolecularFunction | dioxygenase activity | 1.23e-03 | 98 | 95 | 4 | GO:0051213 | |
| GeneOntologyMolecularFunction | integrin binding | 1.50e-03 | 175 | 95 | 5 | GO:0005178 | |
| GeneOntologyBiologicalProcess | biphenyl catabolic process | 2.79e-08 | 8 | 94 | 4 | GO:0070980 | |
| GeneOntologyBiologicalProcess | biphenyl metabolic process | 8.32e-08 | 10 | 94 | 4 | GO:0018879 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 1.95e-07 | 12 | 94 | 4 | GO:0052697 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 2.28e-06 | 21 | 94 | 4 | GO:0052695 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 5.60e-06 | 26 | 94 | 4 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 5.60e-06 | 26 | 94 | 4 | GO:0006063 | |
| GeneOntologyBiologicalProcess | peptidyl-proline hydroxylation to 4-hydroxy-L-proline | 1.47e-05 | 11 | 94 | 3 | GO:0018401 | |
| GeneOntologyBiologicalProcess | benzene-containing compound metabolic process | 2.38e-05 | 37 | 94 | 4 | GO:0042537 | |
| GeneOntologyBiologicalProcess | xenobiotic catabolic process | 2.38e-05 | 37 | 94 | 4 | GO:0042178 | |
| GeneOntologyBiologicalProcess | androgen metabolic process | 2.65e-05 | 38 | 94 | 4 | GO:0008209 | |
| GeneOntologyBiologicalProcess | peptidyl-proline hydroxylation | 3.22e-05 | 14 | 94 | 3 | GO:0019511 | |
| GeneOntologyBiologicalProcess | 4-hydroxyproline metabolic process | 4.01e-05 | 15 | 94 | 3 | GO:0019471 | |
| GeneOntologyBiologicalProcess | excitatory synapse assembly | 5.70e-05 | 46 | 94 | 4 | GO:1904861 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 9.26e-05 | 52 | 94 | 4 | GO:0008210 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | FLNA COL8A2 FAT2 NRXN3 DTX1 DCHS1 GRID2 NECTIN3 ITGA2B ITGAD CD200R1L ITGAM ADAM8 SLITRK1 PTPRT | 1.02e-04 | 1077 | 94 | 15 | GO:0098609 |
| GeneOntologyBiologicalProcess | brain development | EOMES FZD1 FLNA SETD2 DMXL2 RELN CEP120 GRID2 DLX5 ITGAM NR2F1 RBFOX2 FOXC1 | 1.38e-04 | 859 | 94 | 13 | GO:0007420 |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | P4HA2 EGLN2 NAAA ABHD5 ACADSB P4HA1 UGT2B4 UGT2B7 ANKRD26 PNPLA8 UGT2B28 IDH3G UGT2B11 PCMT1 | 2.41e-04 | 1035 | 94 | 14 | GO:0019752 |
| GeneOntologyBiologicalProcess | head development | EOMES FZD1 FLNA SETD2 DMXL2 RELN CEP120 GRID2 DLX5 ITGAM NR2F1 RBFOX2 FOXC1 | 2.67e-04 | 919 | 94 | 13 | GO:0060322 |
| GeneOntologyBiologicalProcess | protein hydroxylation | 2.76e-04 | 28 | 94 | 3 | GO:0018126 | |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | P4HA2 EGLN2 NAAA ABHD5 ACADSB P4HA1 UGT2B4 UGT2B7 ANKRD26 PNPLA8 UGT2B28 IDH3G UGT2B11 PCMT1 | 3.01e-04 | 1058 | 94 | 14 | GO:0043436 |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting dopamine receptor signaling pathway | 3.05e-04 | 6 | 94 | 2 | GO:0007195 | |
| GeneOntologyBiologicalProcess | organic acid metabolic process | P4HA2 EGLN2 NAAA ABHD5 ACADSB P4HA1 UGT2B4 UGT2B7 ANKRD26 PNPLA8 UGT2B28 IDH3G UGT2B11 PCMT1 | 3.19e-04 | 1064 | 94 | 14 | GO:0006082 |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | HOXA3 EOMES FZD1 FLNA SETD2 COL8A2 RELN NRXN3 LPA DCHS1 GRID2 DLX5 ITGA2B AMOTL2 ADAM8 NOP2 FOXC1 | 3.51e-04 | 1483 | 94 | 17 | GO:0048646 |
| GeneOntologyBiologicalProcess | forebrain development | 3.93e-04 | 489 | 94 | 9 | GO:0030900 | |
| GeneOntologyBiologicalProcess | postsynaptic density assembly | 4.95e-04 | 34 | 94 | 3 | GO:0097107 | |
| GeneOntologyBiologicalProcess | synapse assembly | 5.22e-04 | 308 | 94 | 7 | GO:0007416 | |
| GeneOntologyBiologicalProcess | spindle organization | 5.64e-04 | 224 | 94 | 6 | GO:0007051 | |
| GeneOntologyBiologicalProcess | cerebral cortex development | 5.67e-04 | 147 | 94 | 5 | GO:0021987 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 5.74e-04 | 313 | 94 | 7 | GO:0098742 | |
| GeneOntologyBiologicalProcess | protein localization to cell junction | 5.84e-04 | 148 | 94 | 5 | GO:1902414 | |
| GeneOntologyBiologicalProcess | non-proteinogenic amino acid metabolic process | 6.74e-04 | 87 | 94 | 4 | GO:0170041 | |
| GeneOntologyBiologicalProcess | cerebral cortex regionalization | 7.25e-04 | 9 | 94 | 2 | GO:0021796 | |
| GeneOntologyCellularComponent | nuclear outer membrane | 3.10e-05 | 40 | 94 | 4 | GO:0005640 | |
| GeneOntologyCellularComponent | procollagen-proline 4-dioxygenase complex | 5.98e-05 | 3 | 94 | 2 | GO:0016222 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 7.70e-05 | 157 | 94 | 6 | GO:0098839 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 2.96e-04 | 201 | 94 | 6 | GO:0099634 | |
| GeneOntologyCellularComponent | integrin complex | 3.97e-04 | 32 | 94 | 3 | GO:0008305 | |
| Domain | UDPGT | 3.52e-06 | 21 | 95 | 4 | PF00201 | |
| Domain | UDPGT | 3.52e-06 | 21 | 95 | 4 | PS00375 | |
| Domain | UDP_glucos_trans | 3.52e-06 | 21 | 95 | 4 | IPR002213 | |
| Domain | Integrin_alpha | 2.04e-05 | 11 | 95 | 3 | PF00357 | |
| Domain | 2OG-FeII_Oxy_3 | 2.04e-05 | 11 | 95 | 3 | PF13640 | |
| Domain | Gamma_tubulin | 2.56e-05 | 2 | 95 | 2 | IPR002454 | |
| Domain | Integrin_alpha_C_CS | 6.80e-05 | 16 | 95 | 3 | IPR018184 | |
| Domain | P4Hc | 6.80e-05 | 16 | 95 | 3 | SM00702 | |
| Domain | Pro_4_hyd_alph | 6.80e-05 | 16 | 95 | 3 | IPR006620 | |
| Domain | P4Ha_N | 7.65e-05 | 3 | 95 | 2 | PF08336 | |
| Domain | Pro_4_hyd_alph_N | 7.65e-05 | 3 | 95 | 2 | IPR013547 | |
| Domain | Kringle | 8.23e-05 | 17 | 95 | 3 | IPR000001 | |
| Domain | Kringle_CS | 8.23e-05 | 17 | 95 | 3 | IPR018056 | |
| Domain | KRINGLE_2 | 8.23e-05 | 17 | 95 | 3 | PS50070 | |
| Domain | Kringle | 8.23e-05 | 17 | 95 | 3 | PF00051 | |
| Domain | KRINGLE_1 | 8.23e-05 | 17 | 95 | 3 | PS00021 | |
| Domain | KR | 8.23e-05 | 17 | 95 | 3 | SM00130 | |
| Domain | Integrin_alpha-2 | 9.84e-05 | 18 | 95 | 3 | IPR013649 | |
| Domain | Integrin_alpha2 | 9.84e-05 | 18 | 95 | 3 | PF08441 | |
| Domain | Integrin_alpha | 9.84e-05 | 18 | 95 | 3 | IPR000413 | |
| Domain | INTEGRIN_ALPHA | 9.84e-05 | 18 | 95 | 3 | PS00242 | |
| Domain | Int_alpha_beta-p | 1.16e-04 | 19 | 95 | 3 | IPR013519 | |
| Domain | Int_alpha | 1.16e-04 | 19 | 95 | 3 | SM00191 | |
| Domain | 2OG-FeII_Oxy | 1.16e-04 | 19 | 95 | 3 | PF03171 | |
| Domain | WWE | 1.53e-04 | 4 | 95 | 2 | SM00678 | |
| Domain | WWE-dom_subgr | 1.53e-04 | 4 | 95 | 2 | IPR018123 | |
| Domain | FE2OG_OXY | 1.59e-04 | 21 | 95 | 3 | PS51471 | |
| Domain | FG_GAP | 1.83e-04 | 22 | 95 | 3 | PS51470 | |
| Domain | Oxoglu/Fe-dep_dioxygenase | 2.10e-04 | 23 | 95 | 3 | IPR005123 | |
| Domain | FG-GAP | 2.39e-04 | 24 | 95 | 3 | PF01839 | |
| Domain | FG-GAP | 2.39e-04 | 24 | 95 | 3 | IPR013517 | |
| Domain | Integrin_dom | 2.70e-04 | 25 | 95 | 3 | IPR032695 | |
| Domain | Kringle-like | 5.68e-04 | 32 | 95 | 3 | IPR013806 | |
| Domain | 6hp_glycosidase | 7.03e-04 | 8 | 95 | 2 | IPR012341 | |
| Domain | AC_N | 7.03e-04 | 8 | 95 | 2 | IPR032628 | |
| Domain | Adcy | 7.03e-04 | 8 | 95 | 2 | IPR030672 | |
| Domain | - | 7.03e-04 | 8 | 95 | 2 | 1.50.10.10 | |
| Domain | AC_N | 7.03e-04 | 8 | 95 | 2 | PF16214 | |
| Domain | IG_FLMN | 1.12e-03 | 10 | 95 | 2 | SM00557 | |
| Domain | Filamin | 1.37e-03 | 11 | 95 | 2 | PF00630 | |
| Domain | FILAMIN_REPEAT | 1.37e-03 | 11 | 95 | 2 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 1.37e-03 | 11 | 95 | 2 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 1.37e-03 | 11 | 95 | 2 | IPR017868 | |
| Domain | WWE | 1.63e-03 | 12 | 95 | 2 | PS50918 | |
| Domain | WWE | 1.63e-03 | 12 | 95 | 2 | PF02825 | |
| Domain | WWE-dom | 1.63e-03 | 12 | 95 | 2 | IPR004170 | |
| Domain | 6-hairpin_glycosidase-like | 1.93e-03 | 13 | 95 | 2 | IPR008928 | |
| Domain | TPR_2 | 2.10e-03 | 50 | 95 | 3 | PF07719 | |
| Domain | TPR_2 | 2.10e-03 | 50 | 95 | 3 | IPR013105 | |
| Domain | Disintegrin_CS | 2.93e-03 | 16 | 95 | 2 | IPR018358 | |
| Domain | A/G_cyclase_CS | 3.31e-03 | 17 | 95 | 2 | IPR018297 | |
| Domain | EGF_extracell | 3.54e-03 | 60 | 95 | 3 | IPR013111 | |
| Domain | EGF_2 | 3.54e-03 | 60 | 95 | 3 | PF07974 | |
| Domain | Zn_pept | 3.71e-03 | 18 | 95 | 2 | SM00631 | |
| Domain | Nucleotide_cyclase | 3.71e-03 | 18 | 95 | 2 | IPR029787 | |
| Domain | ADAM_CR | 3.71e-03 | 18 | 95 | 2 | PF08516 | |
| Domain | - | 3.71e-03 | 18 | 95 | 2 | 3.30.70.1230 | |
| Domain | GUANYLATE_CYCLASE_1 | 4.14e-03 | 19 | 95 | 2 | PS00452 | |
| Domain | Guanylate_cyc | 4.14e-03 | 19 | 95 | 2 | PF00211 | |
| Domain | GUANYLATE_CYCLASE_2 | 4.14e-03 | 19 | 95 | 2 | PS50125 | |
| Domain | A/G_cyclase | 4.14e-03 | 19 | 95 | 2 | IPR001054 | |
| Domain | CYCc | 4.14e-03 | 19 | 95 | 2 | SM00044 | |
| Domain | CARBOXYPEPT_ZN_2 | 4.14e-03 | 19 | 95 | 2 | PS00133 | |
| Domain | - | 4.58e-03 | 20 | 95 | 2 | 4.10.70.10 | |
| Domain | CARBOXYPEPT_ZN_1 | 4.58e-03 | 20 | 95 | 2 | PS00132 | |
| Domain | - | 4.58e-03 | 20 | 95 | 2 | 3.30.1330.20 | |
| Domain | - | 5.05e-03 | 21 | 95 | 2 | 1.10.287.600 | |
| Domain | Disintegrin | 5.05e-03 | 21 | 95 | 2 | PF00200 | |
| Domain | DISIN | 5.05e-03 | 21 | 95 | 2 | SM00050 | |
| Pathway | REACTOME_PREDNISONE_ADME | 6.06e-06 | 23 | 75 | 4 | MM16639 | |
| Pathway | REACTOME_GLUCURONIDATION | 7.24e-06 | 24 | 75 | 4 | MM14599 | |
| Pathway | REACTOME_GLUCURONIDATION | 8.59e-06 | 25 | 75 | 4 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 8.59e-06 | 25 | 75 | 4 | MM15820 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 8.59e-06 | 25 | 75 | 4 | M605 | |
| Pathway | WP_GLUCURONIDATION | 1.01e-05 | 26 | 75 | 4 | M39404 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 1.37e-05 | 28 | 75 | 4 | M19580 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 5.28e-05 | 39 | 75 | 4 | MM15695 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 6.45e-05 | 41 | 75 | 4 | M7399 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 6.61e-05 | 258 | 75 | 8 | MM14572 | |
| Pathway | REACTOME_ASPIRIN_ADME | 8.54e-05 | 44 | 75 | 4 | M45014 | |
| Pathway | REACTOME_ASPIRIN_ADME | 9.33e-05 | 45 | 75 | 4 | MM15694 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 1.53e-04 | 51 | 75 | 4 | M17726 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 1.65e-04 | 52 | 75 | 4 | M14171 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 2.05e-04 | 55 | 75 | 4 | M14933 | |
| Pathway | PID_INTEGRIN_CS_PATHWAY | 3.44e-04 | 26 | 75 | 3 | M47 | |
| Pathway | KEGG_RETINOL_METABOLISM | 3.69e-04 | 64 | 75 | 4 | M9488 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 3.91e-04 | 65 | 75 | 4 | M39682 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 5.20e-04 | 70 | 75 | 4 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 5.78e-04 | 72 | 75 | 4 | M9257 | |
| Pathway | WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA | 7.04e-04 | 33 | 75 | 3 | M39870 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 7.10e-04 | 76 | 75 | 4 | MM14867 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.06e-03 | 300 | 75 | 7 | M610 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.08e-03 | 85 | 75 | 4 | M16441 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | 1.22e-03 | 10 | 75 | 2 | M19522 | |
| Pathway | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | 1.22e-03 | 10 | 75 | 2 | MM14849 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | 1.22e-03 | 10 | 75 | 2 | MM14668 | |
| Pathway | WP_NPHP1_DELETION_SYNDROME | 1.49e-03 | 11 | 75 | 2 | M48099 | |
| Pubmed | 1.82e-09 | 7 | 95 | 4 | 26074487 | ||
| Pubmed | 3.63e-09 | 8 | 95 | 4 | 32093886 | ||
| Pubmed | 1.08e-08 | 10 | 95 | 4 | 22479190 | ||
| Pubmed | Wnt/β-catenin signaling regulates sequential fate decisions of murine cortical precursor cells. | 1.71e-07 | 46 | 95 | 5 | 25182747 | |
| Pubmed | Loss of Dmrt5 Affects the Formation of the Subplate and Early Corticogenesis. | 1.96e-07 | 19 | 95 | 4 | 31845734 | |
| Pubmed | 4.44e-07 | 23 | 95 | 4 | 30329130 | ||
| Pubmed | HIV-1 Vpr hijacks EDD-DYRK2-DDB1DCAF1 to disrupt centrosome homeostasis. | 6.86e-07 | 7 | 95 | 3 | 29724823 | |
| Pubmed | CoupTFI interacts with retinoic acid signaling during cortical development. | 6.86e-07 | 7 | 95 | 3 | 23472160 | |
| Pubmed | PRUNE2 SETD2 DMXL2 FAT2 BRSK2 ANKRD26 RAB21 JMJD1C SLITRK1 ADAMTSL2 | 1.03e-06 | 493 | 95 | 10 | 15368895 | |
| Pubmed | ASPM and CITK regulate spindle orientation by affecting the dynamics of astral microtubules. | 1.09e-06 | 8 | 95 | 3 | 27562601 | |
| Pubmed | 1.64e-06 | 9 | 95 | 3 | 31086189 | ||
| Pubmed | 2.34e-06 | 10 | 95 | 3 | 16615126 | ||
| Pubmed | Prolonged Mitosis of Neural Progenitors Alters Cell Fate in the Developing Brain. | 2.34e-06 | 10 | 95 | 3 | 26748089 | |
| Pubmed | FLNA SETD2 PTPN13 TCF20 TTC28 RCC1 AMOTL2 SRCAP JMJD1C PCMT1 | 2.69e-06 | 549 | 95 | 10 | 38280479 | |
| Pubmed | HMMR acts in the PLK1-dependent spindle positioning pathway and supports neural development. | 3.21e-06 | 11 | 95 | 3 | 28994651 | |
| Pubmed | 3.21e-06 | 11 | 95 | 3 | 22649246 | ||
| Pubmed | Tight junction protein occludin regulates progenitor Self-Renewal and survival in developing cortex. | 3.21e-06 | 11 | 95 | 3 | 31794381 | |
| Pubmed | 3.21e-06 | 11 | 95 | 3 | 38658571 | ||
| Pubmed | 3.21e-06 | 11 | 95 | 3 | 29021239 | ||
| Pubmed | 4.27e-06 | 12 | 95 | 3 | 33326788 | ||
| Pubmed | 4.27e-06 | 12 | 95 | 3 | 20181597 | ||
| Pubmed | Augmin deficiency in neural stem cells causes p53-dependent apoptosis and aborts brain development. | 4.27e-06 | 12 | 95 | 3 | 34427181 | |
| Pubmed | 4.27e-06 | 12 | 95 | 3 | 20823249 | ||
| Pubmed | 5.54e-06 | 13 | 95 | 3 | 26903504 | ||
| Pubmed | 7.03e-06 | 14 | 95 | 3 | 24381198 | ||
| Pubmed | Normal immune system development in mice lacking the Deltex-1 RING finger domain. | 7.38e-06 | 2 | 95 | 2 | 15684394 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 28119396 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 10222050 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 38081527 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 17635842 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 39093497 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 31395659 | ||
| Pubmed | Proline hydroxylation in collagen supports integrin binding by two distinct mechanisms. | 7.38e-06 | 2 | 95 | 2 | 29615493 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 11336782 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 33649519 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 34218269 | ||
| Pubmed | MTOC reorientation occurs during FcgammaR-mediated phagocytosis in macrophages. | 7.38e-06 | 2 | 95 | 2 | 17442887 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 17263731 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 22806905 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 21679149 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 9211872 | ||
| Pubmed | Filamin depletion blocks endoplasmic spreading and destabilizes force-bearing adhesions. | 7.38e-06 | 2 | 95 | 2 | 21325628 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 15319348 | ||
| Pubmed | Gene knockout analysis of two gamma-tubulin isoforms in mice. | 7.38e-06 | 2 | 95 | 2 | 15893303 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 17287496 | ||
| Pubmed | Single-cell transcriptomic analysis of mouse neocortical development. | 7.57e-06 | 170 | 95 | 6 | 30635555 | |
| Pubmed | 8.77e-06 | 15 | 95 | 3 | 24115331 | ||
| Pubmed | 8.77e-06 | 15 | 95 | 3 | 32097653 | ||
| Pubmed | 1.08e-05 | 16 | 95 | 3 | 18824598 | ||
| Pubmed | Filamin A- and formin 2-dependent endocytosis regulates proliferation via the canonical Wnt pathway. | 1.08e-05 | 16 | 95 | 3 | 27789627 | |
| Pubmed | Loss of RNA-Binding Protein HuR Leads to Defective Ependymal Cells and Hydrocephalus. | 1.08e-05 | 16 | 95 | 3 | 34815315 | |
| Pubmed | 1.08e-05 | 16 | 95 | 3 | 24875059 | ||
| Pubmed | Impaired cortical neurogenesis in plexin-B1 and -B2 double deletion mutant. | 1.08e-05 | 16 | 95 | 3 | 26579598 | |
| Pubmed | Strabismus regulates asymmetric cell divisions and cell fate determination in the mouse brain. | 1.08e-05 | 16 | 95 | 3 | 19332887 | |
| Pubmed | 1.31e-05 | 17 | 95 | 3 | 22017987 | ||
| Pubmed | 1.31e-05 | 17 | 95 | 3 | 37590085 | ||
| Pubmed | Cep55 regulation of PI3K/Akt signaling is required for neocortical development and ciliogenesis. | 1.31e-05 | 17 | 95 | 3 | 34710087 | |
| Pubmed | Genetic analysis of anterior posterior expression gradients in the developing mammalian forebrain. | 1.56e-05 | 18 | 95 | 3 | 17150988 | |
| Pubmed | 1.85e-05 | 19 | 95 | 3 | 30668728 | ||
| Pubmed | Cep120 is essential for kidney stromal progenitor cell growth and differentiation. | 1.85e-05 | 19 | 95 | 3 | 38177914 | |
| Pubmed | Cell Metabolic Alterations due to Mcph1 Mutation in Microcephaly. | 2.18e-05 | 20 | 95 | 3 | 32294449 | |
| Pubmed | 2.18e-05 | 20 | 95 | 3 | 34237032 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 10903841 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 11252955 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 28175289 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 16877351 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 7835904 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 25849143 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 8333863 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 29138287 | ||
| Pubmed | Superoxide-induced Type I collagen secretion depends on prolyl 4-hydroxylases. | 2.21e-05 | 3 | 95 | 2 | 32819558 | |
| Pubmed | Human TUBG2 gene is expressed as two splice variant mRNA and involved in cell growth. | 2.21e-05 | 3 | 95 | 2 | 27015882 | |
| Pubmed | Gain-of-Function Mutation in Filamin A Potentiates Platelet Integrin αIIbβ3 Activation. | 2.21e-05 | 3 | 95 | 2 | 28428218 | |
| Pubmed | GPIbα regulates platelet size by controlling the subcellular localization of filamin. | 2.21e-05 | 3 | 95 | 2 | 22174152 | |
| Pubmed | Prognostic and diagnostic roles of prolyl 4-hydroxylase subunit α members in breast cancer. | 2.21e-05 | 3 | 95 | 2 | 34387118 | |
| Pubmed | Reelin-dependent ApoER2 downregulation uncouples newborn neurons from progenitor cells. | 2.21e-05 | 3 | 95 | 2 | 23259060 | |
| Pubmed | Characterization of the human homologue of the yeast spc98p and its association with gamma-tubulin. | 2.21e-05 | 3 | 95 | 2 | 9566969 | |
| Pubmed | Disrupted filamin A/αIIbβ3 interaction induces macrothrombocytopenia by increasing RhoA activity. | 2.21e-05 | 3 | 95 | 2 | 30602618 | |
| Pubmed | The Aurora A-HP1γ pathway regulates gene expression and mitosis in cells from the sperm lineage. | 2.21e-05 | 3 | 95 | 2 | 26021315 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 12393796 | ||
| Pubmed | T cells develop normally in the absence of both Deltex1 and Deltex2. | 2.21e-05 | 3 | 95 | 2 | 16923970 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 9037414 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 22092298 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 7753822 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 11153914 | ||
| Pubmed | The Role of Integrins αMβ2 (Mac-1, CD11b/CD18) and αDβ2 (CD11d/CD18) in Macrophage Fusion. | 2.21e-05 | 3 | 95 | 2 | 27315778 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 38989458 | ||
| Pubmed | 2.43e-05 | 430 | 95 | 8 | 32581705 | ||
| Pubmed | 2.53e-05 | 21 | 95 | 3 | 38402586 | ||
| Pubmed | 2.93e-05 | 22 | 95 | 3 | 33899739 | ||
| Pubmed | 3.31e-05 | 66 | 95 | 4 | 19898482 | ||
| Pubmed | Primary cilia regulate hippocampal neurogenesis by mediating sonic hedgehog signaling. | 3.36e-05 | 23 | 95 | 3 | 18728187 | |
| Pubmed | 3.36e-05 | 23 | 95 | 3 | 31504280 | ||
| Pubmed | 3.83e-05 | 24 | 95 | 3 | 15858069 | ||
| Pubmed | MicroRNA-34/449 controls mitotic spindle orientation during mammalian cortex development. | 4.35e-05 | 25 | 95 | 3 | 27707753 | |
| Pubmed | Dentate gyrus morphogenesis is regulated by β-catenin function in hem-derived fimbrial glia. | 4.35e-05 | 25 | 95 | 3 | 36196585 | |
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 8395631 | ||
| Pubmed | FOXC1 transcriptional regulatory activity is impaired by PBX1 in a filamin A-mediated manner. | 4.41e-05 | 4 | 95 | 2 | 15684392 | |
| Pubmed | SHARPIN regulates uropod detachment in migrating lymphocytes. | 4.41e-05 | 4 | 95 | 2 | 24210817 | |
| Pubmed | Loss of Necdin impairs myosin activation and delays cell polarization. | 4.41e-05 | 4 | 95 | 2 | 20665884 | |
| Cytoband | 7q21 | 3.26e-04 | 13 | 95 | 2 | 7q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q13 | 3.29e-04 | 157 | 95 | 4 | chr4q13 | |
| Cytoband | 4q13 | 4.37e-04 | 15 | 95 | 2 | 4q13 | |
| Cytoband | 4q13.2 | 1.89e-03 | 31 | 95 | 2 | 4q13.2 | |
| Cytoband | 22q12.1 | 2.02e-03 | 32 | 95 | 2 | 22q12.1 | |
| Cytoband | 10q21.3 | 2.28e-03 | 34 | 95 | 2 | 10q21.3 | |
| Cytoband | 4q21.1 | 2.69e-03 | 37 | 95 | 2 | 4q21.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q21 | 2.71e-03 | 133 | 95 | 3 | chr4q21 | |
| Cytoband | 7q22 | 2.84e-03 | 38 | 95 | 2 | 7q22 | |
| GeneFamily | UDP glucuronosyltransferases | 3.68e-06 | 32 | 60 | 4 | 363 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 2.74e-05 | 18 | 60 | 3 | 1160 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 4.79e-04 | 10 | 60 | 2 | 53 | |
| GeneFamily | Cadherin related | 1.43e-03 | 17 | 60 | 2 | 24 | |
| GeneFamily | Carboxypeptidases | 2.18e-03 | 21 | 60 | 2 | 1321 | |
| GeneFamily | Tubulins | 3.34e-03 | 26 | 60 | 2 | 778 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 3.60e-03 | 27 | 60 | 2 | 47 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_21_PRECICTIVE_ICB_RESISTANCE | 1.03e-05 | 206 | 95 | 7 | MM17087 | |
| Coexpression | NABA_ECM_REGULATORS | 2.61e-05 | 238 | 95 | 7 | M3468 | |
| Coexpression | NABA_ECM_REGULATORS | 2.91e-05 | 242 | 95 | 7 | MM17062 | |
| Coexpression | GSE33292_DN3_THYMOCYTE_VS_TCELL_LYMPHOMA_FROM_TCF1_KO_UP | 4.05e-05 | 173 | 95 | 6 | M9425 | |
| Coexpression | WENG_POR_TARGETS_LIVER_UP | 4.14e-05 | 53 | 95 | 4 | MM1203 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_500 | 3.08e-05 | 41 | 93 | 4 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.26e-05 | 92 | 93 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#4_top-relative-expression-ranked_500 | 5.79e-05 | 48 | 93 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_200 | 7.49e-05 | 19 | 93 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_200_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_200 | 8.77e-05 | 165 | 93 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_200 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.73e-09 | 192 | 94 | 8 | 992d08092edbc68c47b945deb8708379738c239a | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.55e-07 | 189 | 94 | 7 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | (2)_5-FU-(3)_LEPR+_perivascular_cells|World / Stress and Cell class | 2.06e-07 | 197 | 94 | 7 | 434ae0231972acba12d06279908cf407e70511ac | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 2.28e-07 | 200 | 94 | 7 | bad32a95b759fad509401b07bc96a56687c2a592 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.28e-07 | 200 | 94 | 7 | 851c57187db8bc91a393655bca5f13e787a723d4 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Neuronal-GABAergic_neurons|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.34e-06 | 164 | 94 | 6 | 4d7b2d0980fb4f47721fa2891151e2bd892ccb91 | |
| ToppCell | Endothelial-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.82e-06 | 173 | 94 | 6 | a81992965137195d20fc498f750975303961a828 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-06 | 177 | 94 | 6 | 88403b055eb9fdf96e4695fb6e0d78179e30a1e3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-06 | 177 | 94 | 6 | 8903aeaab61abd81a148ea623038c5114b8a183b | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.15e-06 | 178 | 94 | 6 | a107dd98a07086ed0429116095ecda60c9dbef1e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-06 | 180 | 94 | 6 | d76349ecef7c5878bf215e946f032264161eb61b | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-06 | 181 | 94 | 6 | cef034030e6b029a49ae56be37ea1fac1a5c350e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-06 | 183 | 94 | 6 | 738e94b50c4c08c727d4eed0708dda08aa6891b4 | |
| ToppCell | Pericytes-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 2.60e-06 | 184 | 94 | 6 | cd10d351d91a81dd6dc806cb4e0c8d7861c98e0b | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.77e-06 | 186 | 94 | 6 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-06 | 186 | 94 | 6 | d1d01ce46e62944aa9864eda47e8401b5f0d2bdc | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.77e-06 | 186 | 94 | 6 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.77e-06 | 186 | 94 | 6 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-06 | 187 | 94 | 6 | 9c9ae8725905ba0cfe407878006ed06c2480fb72 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.86e-06 | 187 | 94 | 6 | 9225caf66e06ebe57e90d677122acb6498607f36 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-06 | 187 | 94 | 6 | 9e9460e57cdc9cd0a0de2866b140e06d0bc19a8f | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.95e-06 | 188 | 94 | 6 | dc52dd2957be3f40001f0a56f3d9ac9d66ea466e | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.95e-06 | 188 | 94 | 6 | 2ef08313087e91985bcffc46c3798470cdeec49c | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.95e-06 | 188 | 94 | 6 | 1f1604b6dc0a8ad0be3d9aac0bef448459c22465 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.04e-06 | 189 | 94 | 6 | 975e7aa3b862a8b07c2ab8426a14f5cc54998aca | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-06 | 189 | 94 | 6 | f57200c93d39c9bce1adba0a6a1c178c028dd86b | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-06 | 189 | 94 | 6 | fb2253b8463d08b3d28e952a31a23dea2c2d986b | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.04e-06 | 189 | 94 | 6 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.13e-06 | 190 | 94 | 6 | 7df63e5e0dd395676f4fc18cad0d8b2428390943 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.13e-06 | 190 | 94 | 6 | 73d94fbae92029745989a8712eed8b99fd84c193 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.23e-06 | 191 | 94 | 6 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-06 | 191 | 94 | 6 | f76f3f5c7902a3659d8cbe470f96ce57c8a6744d | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.23e-06 | 191 | 94 | 6 | b133ee1c0e58d00ddd2e4e05b01fd04947524c18 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.33e-06 | 192 | 94 | 6 | 26d9207e72bbef5e0046de511e2c9ff752b726f3 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.43e-06 | 193 | 94 | 6 | 9a2c1711dec9dd8c8313bcf25bb888ac8e86c3f3 | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-06 | 193 | 94 | 6 | d0a5f212f8e8a13dbbe3e41df92548ef82eef70b | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.43e-06 | 193 | 94 | 6 | 7fc3ab7261c88c1df71744bf5b17e8e46c4300e0 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.43e-06 | 193 | 94 | 6 | 7c7aa5e2124830d0fa1df11b6413ec6cf780aad0 | |
| ToppCell | Fibroblasts-Pericytes|Fibroblasts / lung cells shred on cell class, cell subclass, sample id | 3.64e-06 | 195 | 94 | 6 | c2ebc0b33bda9b35b9ef26d69e5d2c6acfdb6ff1 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.75e-06 | 196 | 94 | 6 | 5159d8625d80c20eb28157b2603c8bde9d377a35 | |
| ToppCell | Pericytes|World / shred by cell class for parenchyma | 3.75e-06 | 196 | 94 | 6 | 8e7ecbe77d312a7fc6aadd8fd52c13dd1834cc7e | |
| ToppCell | (5)_Fibroblast-K_(Pericytes)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.75e-06 | 196 | 94 | 6 | e3c89c5bd674289738d5590ebfd30c605f5156a5 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.75e-06 | 196 | 94 | 6 | 5146976881d79642ebe5dcbcf89e0252713a9ef2 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.75e-06 | 196 | 94 | 6 | 208ddedd29e1b9ca89cbb9b527c2e193a44cada2 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes-Fibromyocytes_L.2.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.75e-06 | 196 | 94 | 6 | 6b5b7dbcb2cce8a736e44145a01290905876a5e9 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.75e-06 | 196 | 94 | 6 | ebac1d6af7a5732707d82d01285c086b19d8ae62 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.86e-06 | 197 | 94 | 6 | 1a6b2ca94a4634c24cd95481576c955b20000a5f | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.97e-06 | 198 | 94 | 6 | 55d2ed345101bec4b73f1242ba8c4d73073b7e88 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.97e-06 | 198 | 94 | 6 | 1e1ea54f0c234f3b6d29064c4881d8a0c0949a75 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Smooth_muscle-1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 3.97e-06 | 198 | 94 | 6 | 0f1feed8a37293ae02465909f99548ab58dc7ce5 | |
| ToppCell | PSB|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.97e-06 | 198 | 94 | 6 | 4e6b0d1abc55d7a0d89bd7ecf0f13dc5bed66626 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.97e-06 | 198 | 94 | 6 | 8602a518b5913625b1dd3cbc3c7e6efde0d5d942 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Pericyte-Muscle_pericyte_systemic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.97e-06 | 198 | 94 | 6 | 0dc5806714fb3d3983e9d19fa7a108e93a8090ed | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.09e-06 | 199 | 94 | 6 | 0a145172787f40d0fdaf21188d539ffaf7ece3e4 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.09e-06 | 199 | 94 | 6 | 6200618e029063486719479c41eaf31798bd13cf | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.09e-06 | 199 | 94 | 6 | 379bbd9cecf466b902411c54d74bd9885285b1ba | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.09e-06 | 199 | 94 | 6 | c2903b1a4b91e94bbdaa909bacefe901255cf248 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Neuronal-Interneuron|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 7.15e-06 | 126 | 94 | 5 | ec445ec097c9c45cd47b8cfa8c140df5b298695e | |
| ToppCell | (07)_Ionocytes-(1)_GFP|(07)_Ionocytes / shred by cell type by condition | 1.51e-05 | 147 | 94 | 5 | d398f49553ece2786c51e16e4bee028fb3833149 | |
| ToppCell | COVID-19-kidney-Lymphatic_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.56e-05 | 148 | 94 | 5 | f777aa1674e898e2594b2b7c029d3d05dda04df9 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-Klrb1a/b/c(-)_NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-05 | 153 | 94 | 5 | cb144b8c487286384b47fdff88ff98fcf0508899 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-05 | 158 | 94 | 5 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-05 | 158 | 94 | 5 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 2.20e-05 | 159 | 94 | 5 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.34e-05 | 161 | 94 | 5 | 64891f6f2ee1693c8481e951b9346e2f92d602e3 | |
| ToppCell | Bronchial_Biopsy-Endothelial-Lymphatic|Endothelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.48e-05 | 163 | 94 | 5 | 961c3a1303108afd680365466045f3460a30a7b0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-05 | 164 | 94 | 5 | 43630a448f4369fa9e4e3eccdf3b9f29cec16c39 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-05 | 164 | 94 | 5 | 108fbecb56d69a675d6ce6e826a873ae528f2fd7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-05 | 164 | 94 | 5 | 46208f18325976c89f572f6627aea0582142b92d | |
| ToppCell | metastatic_Brain-Fibroblasts-Smooth_muscle_cells|metastatic_Brain / Location, Cell class and cell subclass | 2.71e-05 | 166 | 94 | 5 | 0da2c6ea1e62f1aafabafbbfbbcc6f7011739346 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.87e-05 | 168 | 94 | 5 | af82e07d1eec51fc6530155f37addbce6221885d | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.87e-05 | 168 | 94 | 5 | 95dc690c1987b05685d36e6bb20eb79308696e30 | |
| ToppCell | Endothelial-B-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 2.87e-05 | 168 | 94 | 5 | 4977c3837fbb1f36c89fddd5764e37290ac25ad8 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_C|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.04e-05 | 170 | 94 | 5 | 81341bf4fe090af70b2091b6b2579ed08d76e22d | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-05 | 171 | 94 | 5 | ab21f20ec041cbaacccbd7da4dccdb77ec8bc5c6 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-05 | 171 | 94 | 5 | 913bae728b5e653771a27c79a309eb023699f1d0 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-05 | 171 | 94 | 5 | f28b2336057e353b96a6ff4581ec9fd0ca0789d9 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-05 | 171 | 94 | 5 | 97ad2cfff568a9d006ab1d2e6e00946ee4e3beb3 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.30e-05 | 173 | 94 | 5 | fc2602b2ce051cd4c33957d7e3d041ff8a529883 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.30e-05 | 173 | 94 | 5 | 901b8e6909c1f3849906fad9cee17b8f0bab050d | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.39e-05 | 174 | 94 | 5 | 4da79da7a09ee1e345102c5331675ebcdbe56171 | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.49e-05 | 175 | 94 | 5 | 294a70786260c9a2b1ba16c88819d786698609e7 | |
| ToppCell | Pericytes-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 3.49e-05 | 175 | 94 | 5 | ddf721023a7afc8085c5de17aa254a6575444c0f | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.49e-05 | 175 | 94 | 5 | 798f33bd340261c048b7b45c842b2ccd1ea1fb60 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-05 | 176 | 94 | 5 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-05 | 177 | 94 | 5 | 065bebd22031f143e90a407f952b444a3f8818c7 | |
| ToppCell | facs-Marrow-Granulocytes-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-05 | 177 | 94 | 5 | eb304f20aab075bd17aa3aef819386c0e1a235bd | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.78e-05 | 178 | 94 | 5 | c20f050344a2e120e685e2a7fe36c6dfc1dc37b6 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.89e-05 | 179 | 94 | 5 | e860dca9b28ac5af61804bfd729cd39257cdb352 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial-LEC2_(MADCAM1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.89e-05 | 179 | 94 | 5 | dfd5b25f2a6a5a8bf4714f1516cb0997de72b06f | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-05 | 180 | 94 | 5 | 35c73670da90cb6924e822a2426d13a675685f09 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-05 | 180 | 94 | 5 | 6ac62bf1251978c8c12e715f7b73144fca619794 | |
| ToppCell | Endothelial-B-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 4.10e-05 | 181 | 94 | 5 | 4fe0215d08f03d4e24749d70fce01b7aa22906fd | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.10e-05 | 181 | 94 | 5 | 071f9bb5d39070cdc473d9b0e094d196bc702b56 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.10e-05 | 181 | 94 | 5 | 566249e04dd491e6287ad2101b7b1ab11031ed8b | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.10e-05 | 181 | 94 | 5 | db9528dc7cb0230e4c36cb27da69102c588c7ee9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-05 | 182 | 94 | 5 | 904804813849b7f7f716ba1554d33b07bc0a701e | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.20e-05 | 182 | 94 | 5 | c7f2d24697affa530b748ab32b1d40bdc1bdc20a | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.20e-05 | 182 | 94 | 5 | d95635b74e8cd8bc00bfe40340806b59fb9bee43 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-05 | 182 | 94 | 5 | 5d8b7fe18286e27f0f50c5d2d9be56850e2cb8f4 | |
| Drug | C1 11-32 | 8.32e-07 | 18 | 95 | 4 | CID000443077 | |
| Drug | C11131 | 8.32e-07 | 18 | 95 | 4 | CID000443076 | |
| Drug | T4-G | 1.05e-06 | 19 | 95 | 4 | CID000152424 | |
| Drug | estriol-16-glucuronide | 1.61e-06 | 21 | 95 | 4 | CID000122281 | |
| Drug | estradiol-3-glucuronide | 2.37e-06 | 23 | 95 | 4 | CID000066651 | |
| Drug | L-idaro-1,4-lactone | 5.39e-06 | 28 | 95 | 4 | CID000078997 | |
| Drug | 7-hydroxycoumarin glucuronide | 6.24e-06 | 29 | 95 | 4 | CID000125641 | |
| Drug | 2-methoxyestradiol | 6.62e-06 | 236 | 95 | 8 | CID000001573 | |
| Drug | AC1Q6OQG | 1.06e-05 | 33 | 95 | 4 | CID000009686 | |
| Drug | BP-3,6-quinol | 1.06e-05 | 33 | 95 | 4 | CID000119292 | |
| Drug | AC1NOWCJ | 1.35e-05 | 35 | 95 | 4 | CID005120112 | |
| Drug | 3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | 1.35e-05 | 35 | 95 | 4 | CID010436171 | |
| Drug | estrone-3-glucuronide | 1.35e-05 | 35 | 95 | 4 | CID000115255 | |
| Drug | l-borneol | 1.69e-05 | 37 | 95 | 4 | CID000010049 | |
| Drug | 2-hydroxyestriol | 1.72e-05 | 2 | 95 | 2 | ctd:C008012 | |
| Drug | Tiabendazole [148-79-8]; Down 200; 19.8uM; MCF7; HT_HG-U133A | 1.78e-05 | 195 | 95 | 7 | 4402_DN | |
| Drug | Probenecid [57-66-9]; Down 200; 14uM; MCF7; HT_HG-U133A | 1.90e-05 | 197 | 95 | 7 | 4771_DN | |
| Drug | Monensin sodium salt [22373-78-0]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 1.90e-05 | 197 | 95 | 7 | 3443_DN | |
| Drug | Tocopherol (R,S) [10191-41-0]; Down 200; 9.2uM; HL60; HT_HG-U133A | 1.96e-05 | 198 | 95 | 7 | 1320_DN | |
| Drug | Paromomycin sulfate [1263-89-4]; Up 200; 5.6uM; MCF7; HT_HG-U133A | 1.96e-05 | 198 | 95 | 7 | 3356_UP | |
| Drug | Chlorogenic acid [327-97-9]; Down 200; 11.2uM; HL60; HT_HG-U133A | 1.96e-05 | 198 | 95 | 7 | 1346_DN | |
| Drug | valdecoxib; Down 200; 10uM; MCF7; HT_HG-U133A | 2.02e-05 | 199 | 95 | 7 | 6403_DN | |
| Drug | Ketorolac tromethamine [74103-07-4]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 2.02e-05 | 199 | 95 | 7 | 6489_UP | |
| Drug | Neomycin sulfate [1405-10-3]; Up 200; 4.2uM; HL60; HG-U133A | 2.02e-05 | 199 | 95 | 7 | 1383_UP | |
| Drug | harmol | 2.32e-05 | 40 | 95 | 4 | CID000068094 | |
| Drug | testosterone glucuronide | 2.56e-05 | 41 | 95 | 4 | CID000108192 | |
| Drug | 2-AF | 2.56e-05 | 41 | 95 | 4 | CID000005800 | |
| Drug | butylated hydroxytoluene | 3.03e-05 | 143 | 95 | 6 | CID000031404 | |
| Drug | androsterone glucuronide | 3.10e-05 | 43 | 95 | 4 | CID000114833 | |
| Drug | 7,8-benzoquinoline | 3.10e-05 | 43 | 95 | 4 | CID000009191 | |
| Drug | MS-222 | 3.40e-05 | 44 | 95 | 4 | CID000011400 | |
| Drug | Mk 0852 | 3.79e-05 | 16 | 95 | 3 | CID000164406 | |
| Drug | thryroxine | 3.91e-05 | 302 | 95 | 8 | CID000000853 | |
| Drug | procaterol | 4.81e-05 | 48 | 95 | 4 | CID000004916 | |
| Drug | salicylamide | 4.81e-05 | 48 | 95 | 4 | CID000005147 | |
| Drug | 5 alpha-dihydroaldosterone | 5.15e-05 | 3 | 95 | 2 | CID003036614 | |
| Drug | dinophysistoxin-4 | 5.15e-05 | 3 | 95 | 2 | CID006441267 | |
| Drug | oxypertine | 5.22e-05 | 49 | 95 | 4 | CID000004640 | |
| Drug | AC1L1EKQ | 6.60e-05 | 52 | 95 | 4 | CID000002834 | |
| Drug | AC1NQGK1 | 6.60e-05 | 52 | 95 | 4 | CID005195977 | |
| Drug | oxazepam | 7.12e-05 | 53 | 95 | 4 | CID000004616 | |
| Drug | OH-H | 7.12e-05 | 53 | 95 | 4 | CID000656932 | |
| Drug | 7-methoxycoumarin | 9.48e-05 | 57 | 95 | 4 | CID000010748 | |
| Drug | phenolphthalein | 1.02e-04 | 58 | 95 | 4 | CID000004764 | |
| Drug | fenoprofen | 1.02e-04 | 22 | 95 | 3 | CID000003342 | |
| Drug | urochloralic acid | 1.09e-04 | 59 | 95 | 4 | CID003036914 | |
| Drug | 4-hydroxybiphenyl | 1.09e-04 | 59 | 95 | 4 | CID000007103 | |
| Drug | 4-hydroxyestrone | 1.09e-04 | 59 | 95 | 4 | CID000018418 | |
| Drug | acetaminophen glucuronide | 1.09e-04 | 59 | 95 | 4 | CID000083944 | |
| Drug | SN-38G | 1.09e-04 | 59 | 95 | 4 | CID000443154 | |
| Drug | UDP-alpha-d-xylopyranose | 1.16e-04 | 60 | 95 | 4 | CID000001165 | |
| Drug | AC1L3VO5 | 1.27e-04 | 116 | 95 | 5 | CID000123015 | |
| Drug | NAIN | 1.34e-04 | 24 | 95 | 3 | CID000195228 | |
| Drug | TL-99 | 1.34e-04 | 24 | 95 | 3 | CID000122132 | |
| Drug | Dipyridamole [58-32-2]; Up 200; 8uM; HL60; HG-U133A | 1.34e-04 | 187 | 95 | 6 | 2017_UP | |
| Drug | fibrates | 1.37e-04 | 118 | 95 | 5 | CID000002797 | |
| Drug | 3-OHBaP | 1.40e-04 | 63 | 95 | 4 | CID000025890 | |
| Drug | deferoxamine mesylate salt; Up 200; 100uM; PC3; HG-U133A | 1.47e-04 | 190 | 95 | 6 | 460_UP | |
| Drug | AAGTP | 1.49e-04 | 64 | 95 | 4 | CID000656407 | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.51e-04 | 191 | 95 | 6 | 1059_DN | |
| Drug | Hymecromone | 1.51e-04 | 25 | 95 | 3 | ctd:D006923 | |
| Drug | Hydroxytacrine maleate (R,S) [118909-22-1]; Down 200; 12.2uM; HL60; HT_HG-U133A | 1.64e-04 | 194 | 95 | 6 | 2430_DN | |
| Drug | Metolazone [17560-51-9]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.69e-04 | 195 | 95 | 6 | 1514_DN | |
| Drug | Delcorine; Down 200; 8.4uM; MCF7; HT_HG-U133A | 1.69e-04 | 195 | 95 | 6 | 4737_DN | |
| Drug | Estradiol-17 beta [50-28-2]; Up 200; 14.6uM; PC3; HT_HG-U133A | 1.69e-04 | 195 | 95 | 6 | 6718_UP | |
| Drug | retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A | 1.69e-04 | 195 | 95 | 6 | 6971_DN | |
| Drug | 2,7,8-trihydroxyanthraquinone | 1.71e-04 | 5 | 95 | 2 | CID000065739 | |
| Drug | phenolphthalin | 1.71e-04 | 5 | 95 | 2 | CID000066494 | |
| Drug | 5-azidopyridine-2-carboxylic acid | 1.71e-04 | 5 | 95 | 2 | CID003037871 | |
| Drug | hyodeoxycholic acid | 1.71e-04 | 5 | 95 | 2 | ctd:C010471 | |
| Drug | Pneumocandin Co | 1.71e-04 | 5 | 95 | 2 | CID000072974 | |
| Drug | Amobarbital | 1.71e-04 | 5 | 95 | 2 | ctd:D000654 | |
| Drug | S 0885 | 1.71e-04 | 5 | 95 | 2 | CID003081128 | |
| Drug | S 4404 | 1.71e-04 | 5 | 95 | 2 | CID000164452 | |
| Drug | Rib-RibA | 1.71e-04 | 5 | 95 | 2 | CID003082286 | |
| Drug | carmustine; Up 200; 100uM; MCF7; HT_HG-U133A | 1.74e-04 | 196 | 95 | 6 | 6888_UP | |
| Drug | Metrizamide [31112-62-6]; Down 200; 5uM; MCF7; HT_HG-U133A | 1.74e-04 | 196 | 95 | 6 | 3255_DN | |
| Drug | Chlortetracycline hydrochloride [64-72-2]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 1.74e-04 | 196 | 95 | 6 | 5360_DN | |
| Drug | Pinacidil [85371-64-8]; Down 200; 16.4uM; HL60; HT_HG-U133A | 1.74e-04 | 196 | 95 | 6 | 2406_DN | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 1.78e-04 | 197 | 95 | 6 | 3620_DN | |
| Drug | Merbromin [129-16-8]; Down 200; 5uM; MCF7; HT_HG-U133A | 1.78e-04 | 197 | 95 | 6 | 3439_DN | |
| Drug | Heliotrine [303-33-3]; Up 200; 12.8uM; PC3; HT_HG-U133A | 1.78e-04 | 197 | 95 | 6 | 3717_UP | |
| Drug | Amprolium hydrochloride [137-88-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 1.83e-04 | 198 | 95 | 6 | 4825_DN | |
| Drug | Flunixin meglumine [42461-84-7]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 1.83e-04 | 198 | 95 | 6 | 4735_DN | |
| Drug | Megestrol acetate [595-33-5]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 1.83e-04 | 198 | 95 | 6 | 6468_DN | |
| Drug | Zomepirac sodium salt [64092-48-4]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 1.88e-04 | 199 | 95 | 6 | 6815_UP | |
| Drug | Diprophylline [479-18-5]; Up 200; 15.8uM; PC3; HT_HG-U133A | 1.88e-04 | 199 | 95 | 6 | 1811_UP | |
| Drug | Diltiazem hydrochloride [33286-22-5]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 1.88e-04 | 199 | 95 | 6 | 5309_DN | |
| Drug | Hexetidine [141-94-6]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.88e-04 | 199 | 95 | 6 | 6319_DN | |
| Drug | Meldola | 1.89e-04 | 68 | 95 | 4 | CID000081507 | |
| Drug | Lynestrenol [52-76-6]; Down 200; 14uM; PC3; HG-U133A | 1.94e-04 | 200 | 95 | 6 | 1953_DN | |
| Drug | Benzonatate [104-31-4]; Down 200; 6.6uM; PC3; HT_HG-U133A | 1.94e-04 | 200 | 95 | 6 | 6334_DN | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 1.94e-04 | 200 | 95 | 6 | 3405_DN | |
| Drug | methoxyresorufin | 2.00e-04 | 69 | 95 | 4 | CID000119220 | |
| Drug | eugenol | 2.48e-04 | 73 | 95 | 4 | CID000003314 | |
| Drug | 2,2,2-trichloroethanol | 2.48e-04 | 73 | 95 | 4 | CID000008259 | |
| Drug | dealanylalahopcin | 2.56e-04 | 6 | 95 | 2 | CID000125989 | |
| Drug | methylsilatrane | 2.56e-04 | 6 | 95 | 2 | CID000016797 | |
| Drug | 2-hydroxyestriol | 2.56e-04 | 6 | 95 | 2 | CID000014688 | |
| Drug | Dns-phe-leu-arg | 2.56e-04 | 6 | 95 | 2 | CID000133939 | |
| Disease | plasma clozapine-to-N-desmethylclozapine ratio measurement | 2.59e-06 | 9 | 94 | 3 | EFO_0600040 | |
| Disease | X-19141 measurement | 8.75e-06 | 13 | 94 | 3 | EFO_0800799 | |
| Disease | complex cortical dysplasia with other brain malformations 4 (implicated_via_orthology) | 1.00e-05 | 2 | 94 | 2 | DOID:0090138 (implicated_via_orthology) | |
| Disease | Adenoid Cystic Carcinoma | 1.75e-05 | 100 | 94 | 5 | C0010606 | |
| Disease | phosphatidylcholine 36:4 measurement | 2.47e-05 | 18 | 94 | 3 | EFO_0010382 | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 3.01e-05 | 3 | 94 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 3.01e-05 | 3 | 94 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | disease progression measurement | 4.39e-05 | 61 | 94 | 4 | EFO_0008336 | |
| Disease | X-24947 measurement | 4.61e-05 | 22 | 94 | 3 | EFO_0800910 | |
| Disease | Malignant Cystosarcoma Phyllodes | 9.98e-05 | 5 | 94 | 2 | C0600066 | |
| Disease | Phyllodes Tumor | 9.98e-05 | 5 | 94 | 2 | C0010701 | |
| Disease | vitamin D deficiency | 2.25e-04 | 37 | 94 | 3 | EFO_0003762 | |
| Disease | Neurodevelopmental Disorders | 2.27e-04 | 93 | 94 | 4 | C1535926 | |
| Disease | mitral valve prolapse (is_implicated_in) | 3.56e-04 | 9 | 94 | 2 | DOID:988 (is_implicated_in) | |
| Disease | response to carboplatin, response to antineoplastic agent | 4.44e-04 | 10 | 94 | 2 | GO_0097327, GO_0097328 | |
| Disease | vitamin D measurement, COVID-19 | 5.19e-04 | 49 | 94 | 3 | EFO_0004631, MONDO_0100096 | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 7.65e-04 | 13 | 94 | 2 | C1846647 | |
| Disease | C-X-C motif chemokine 11 measurement | 8.91e-04 | 14 | 94 | 2 | EFO_0008057 | |
| Disease | diverticular disease | 9.66e-04 | 236 | 94 | 5 | EFO_0009959 | |
| Disease | response to opioid | 9.86e-04 | 61 | 94 | 3 | EFO_0008541 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.02e-03 | 239 | 94 | 5 | EFO_0008317, EFO_0020945 | |
| Disease | Cerebrovascular accident | 1.03e-03 | 62 | 94 | 3 | C0038454 | |
| Disease | ascending aortic diameter | 1.06e-03 | 140 | 94 | 4 | EFO_0021787 | |
| Disease | Spondyloepiphyseal Dysplasia | 1.17e-03 | 16 | 94 | 2 | C0038015 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 1.17e-03 | 16 | 94 | 2 | C3541456 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 1.17e-03 | 16 | 94 | 2 | C4551479 | |
| Disease | Schwartz-Jampel Syndrome | 1.17e-03 | 16 | 94 | 2 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 1.17e-03 | 16 | 94 | 2 | C0025237 | |
| Disease | Van Buchem disease | 1.32e-03 | 17 | 94 | 2 | C0432272 | |
| Disease | alkaline phosphatase measurement | WIPI1 PGGHG TECTB UGT2B4 UGT2B7 DLX5 UGT2B11 JMJD1C ADCY5 ADAMTSL2 | 1.47e-03 | 1015 | 94 | 10 | EFO_0004533 |
| Disease | response to platinum based chemotherapy | 1.49e-03 | 18 | 94 | 2 | EFO_0004647 | |
| Disease | Autistic Disorder | 1.51e-03 | 261 | 94 | 5 | C0004352 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 1.66e-03 | 19 | 94 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | Osteochondrodysplasias | 1.66e-03 | 19 | 94 | 2 | C0029422 | |
| Disease | cerebral infarction (is_marker_for) | 1.66e-03 | 19 | 94 | 2 | DOID:3526 (is_marker_for) | |
| Disease | Dyschondroplasias | 1.66e-03 | 19 | 94 | 2 | C0013366 | |
| Disease | intellectual disability (implicated_via_orthology) | 1.79e-03 | 75 | 94 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | Multiple Epiphyseal Dysplasia | 1.84e-03 | 20 | 94 | 2 | C0026760 | |
| Disease | docosahexaenoic acid to total fatty acids percentage | 2.03e-03 | 21 | 94 | 2 | EFO_0022262 | |
| Disease | progression free survival, ovarian serous carcinoma | 2.23e-03 | 22 | 94 | 2 | EFO_0004920, EFO_1001516 | |
| Disease | Sensorineural Hearing Loss (disorder) | 2.43e-03 | 23 | 94 | 2 | C0018784 | |
| Disease | Carcinoma, Pancreatic Ductal | 2.65e-03 | 24 | 94 | 2 | C0887833 | |
| Disease | medial orbital frontal cortex volume measurement | 2.87e-03 | 25 | 94 | 2 | EFO_0010315 | |
| Disease | myeloid white cell count | 3.02e-03 | 937 | 94 | 9 | EFO_0007988 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LSDFYYGQHKGDGQP | 276 | P59817 | |
| YYAAQQAGTRPHAGD | 116 | Q9Y2J4 | |
| DNYDSSHQIVPGGRY | 456 | O95936 | |
| LPSNYGQGLGDSLYA | 666 | Q8IZF5 | |
| YYQGHIRGNPDSFVA | 136 | Q9P0K1 | |
| PEANILGQIGHGYKY | 271 | P45954 | |
| SGDGVTHNVPIYEGY | 156 | P63267 | |
| INLSQYGPAYFGQEH | 1496 | Q8TDJ6 | |
| LNYLNGDYEVEPGCG | 611 | O95622 | |
| GQDHCFYQGHVEGYP | 101 | P78325 | |
| GEGAYSQPGYHVRDR | 31 | Q9UPS8 | |
| LTGHGYPDANYLDNV | 586 | Q9Y2E6 | |
| QPGHSHLYNNRYAGD | 26 | Q8N4T0 | |
| QYHGVNGSAGSYPAK | 76 | P56178 | |
| AHFTYPRALQEYQGG | 91 | A7MBM2 | |
| VYGFGLSNYHQLGTP | 261 | P18754 | |
| FHALGPIYYRDSNGA | 81 | Q9UL25 | |
| GYRGPGYLSADQHGQ | 946 | Q9H0J4 | |
| EYGVPHTQDYAGQTG | 51 | O43251 | |
| GDPLNGHCYLSGYIS | 176 | P10589 | |
| APSPGYNSHLQYGAD | 56 | P78411 | |
| DPDAGANGHVTYYLG | 1881 | Q96JQ0 | |
| YDVFGDPAYLQLAHG | 76 | O43813 | |
| DYDPHAHGLQGNGSY | 341 | O43365 | |
| PQDCYHGAGEQYRGT | 351 | Q2TV78 | |
| GHIYHGRNLDYPFGN | 136 | Q02083 | |
| GQAHPSASYNQLGLY | 846 | Q15652 | |
| KDGGAQHAQYVGPYR | 6 | Q8IWQ3 | |
| GYYRGIVVTPDGNFH | 121 | Q6Q8B3 | |
| ADRGYGIALQHGSPY | 766 | O43424 | |
| APGDYDVNITYGGAH | 1391 | O75369 | |
| LGSQAFYPGRQHDYL | 36 | Q9NRY7 | |
| DHGENGYVTYSIAGP | 486 | Q9NYQ8 | |
| VPQLEYHCLGGFYGN | 3826 | Q9NYQ8 | |
| GYIHYVFDLGNGPNV | 926 | Q9Y4C0 | |
| HDPFTYDYQSLQIGG | 26 | O00168 | |
| ENEGAGPYLLNGSYL | 501 | Q86TH1 | |
| YPNGEGGLGEHNYCR | 71 | Q96MU8 | |
| DLHQGPDFQGARYLY | 146 | Q32M88 | |
| TGHGYPDASYLDNVL | 591 | Q86Y01 | |
| PGEGVLLHYSYDNGI | 791 | P78509 | |
| GQLAPYAHGDSLYFN | 3296 | P78509 | |
| GDPHSDYINANYIDG | 936 | O14522 | |
| LQVANYGVGGQYEPH | 416 | O15460 | |
| LIGAPHYYEQTRGGQ | 476 | Q13349 | |
| QVANYGVGGQYEPHF | 416 | P13674 | |
| NGNEHLGYGFNRPYA | 281 | Q9H7U1 | |
| AYAQNHGVYLTDPQG | 181 | Q8N0W3 | |
| QYNGERGISVPDHGY | 101 | Q9UP38 | |
| ACLNGDYEVEPGYGH | 446 | Q08828 | |
| PGLVAGANYGHVYAV | 291 | P51553 | |
| LNEEGGYHQIGPAEY | 171 | Q8N960 | |
| PFLDDSPEYGLHGYQ | 341 | Q8NCQ5 | |
| TYSLNVTYGGHQVPG | 1421 | P21333 | |
| DYVNCGHVTAYGPGL | 1861 | P21333 | |
| AHAEQYPGGMARAYG | 51 | Q12948 | |
| ANSGYYEAHPVTNGI | 171 | Q9UN86 | |
| RTLYNGHSGYNPATG | 596 | P25067 | |
| MGHPDQNEQGYYLGS | 796 | Q6V1X1 | |
| NLHGGDLVANYPYDE | 246 | P16870 | |
| LAPQTYLNGHYGDAA | 551 | Q5T1N1 | |
| FIAHQGRDVQGYYPG | 21 | Q5SVJ3 | |
| RPGVQECYHGNGQSY | 136 | P08519 | |
| PGVQECYHGNGQSYR | 251 | P08519 | |
| RPGVQECYHGNGQSY | 706 | P08519 | |
| PGVQECYHGNGQSYR | 821 | P08519 | |
| CYPGNGLGYVRHVDN | 286 | Q96KS0 | |
| GGYDDDQGSYVQVPH | 201 | Q92630 | |
| AALHGQEGYVPRNYF | 801 | Q8WUF5 | |
| ALQAEYGDYQPEVHG | 706 | Q12923 | |
| APGYFAEYALGNDLH | 611 | Q9NP80 | |
| NEIIFGLNDGYYGAP | 151 | Q9P2Y5 | |
| GYAEEAPYDAIHVGA | 146 | P22061 | |
| ISHGGYYGDGLNAII | 2906 | Q8WUY3 | |
| AGNLTNAYVYEVGPG | 51 | Q8WVM0 | |
| NGVHEGGYYQFVIPD | 61 | Q96PL2 | |
| NGYPDLIVGAYGANQ | 461 | P08514 | |
| LIGAPHYYEQTRGGQ | 476 | P11215 | |
| GLLFPQHGDYQYGRN | 371 | Q96K37 | |
| ELLQQYAGAYAPGSG | 446 | Q6ZRS2 | |
| GATPEYLAGHYMLQG | 356 | P46087 | |
| PAGAYIQNEHSYQVG | 221 | Q9BT49 | |
| AILGAGHYVYADQPE | 321 | Q8WTS1 | |
| AVYGQGYSPNSGDVQ | 121 | Q9H3H3 | |
| GPYNADGAHRVYDCG | 676 | Q96PX8 | |
| YNPENIYLSEHGGGA | 86 | P23258 | |
| GANGIYEAIYHGIPM | 376 | P06133 | |
| ASHPGYYGNLVEESL | 526 | O95759 | |
| GSLAGVGAYQLYQDP | 46 | A8MWL7 | |
| EATYAYGGPENLHLG | 1516 | Q86WI1 | |
| LGGVSHYQQDYTGPF | 146 | Q9UGU0 | |
| AYGDPNAGLNSQLHY | 1071 | Q9UGU0 | |
| GANGIYEAIYHGIPM | 376 | O75310 | |
| YQQPDSSYGACGGHK | 1271 | Q9BYW2 | |
| GFYHNQGCYELISGP | 211 | O75841 | |
| HIGNGSNYIKSQGYP | 161 | Q9UJU3 | |
| GHVYTAIGDYPNALA | 321 | Q96AY4 | |
| YNPENIYLSEHGGGA | 86 | Q9NRH3 | |
| GHLYMYNLDPQDGGE | 336 | Q5MNZ9 | |
| GANGIYEAIYHGIPM | 376 | Q9BY64 | |
| GANGIYEAIYHGIPM | 376 | P16662 | |
| ILGGGHYVTYAKNPN | 1521 | Q8NFA0 | |
| HPQYGFSVQGEYQGR | 106 | Q9NQS3 |